Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Australian researchers conducted experiments on mice that they fed only every other day.
A roundup of POZ’s reporting on studies presented at the Mexico City conference about HIV treatment, vaccines, PrEP and other concerns.
Australia has led the world in an aggressive push to provide its citizens with low-cost treatment for the virus.
Researchers analyzed health data regarding modern hep C treatments specific to New South Wales.
The nation has provided unrestricted access to hepatitis C treatment since 2016.
Australian scientists studying the virus have tracked ancient human migration patterns.
Matt Heskett discusses his journey with hepatitis C for the first time with the press.
Doctors are finding ways to diagnose and treat this difficult-to-reach demographic.
A speedy overview of the major scientific findings presented at the International AIDS Conference in Amsterdam (AIDS 2018)
But only a small fraction of those living with the virus worldwide have been cured.
Highlights from HIV and hepatitis C research presented at the 2018 Conference on Retroviruses and Opportunistic Infections (CROI) in Boston
An annual surveillance report on STIs and other blood-borne illnesses also found that new cases of hepatitis B are down among youths.
Epclusa! Now available via our great Australian health care system
Melbourne and Amsterdam have a much better handle on hep C rates among injection drug users than Baltimore, San Francisco or Montreal.
Widespread treatment offers the possibility of eliminating hepatitis C as a public health threat.
However, eight weeks of sofosbuvir/velpatasvir/voxilaprevir worked as well as 12 weeks of Epclusa for those with genotype 3 and cirrhosis.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.